Chunying Wu Selected Research

Chunying Wu Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 01/2009
6	Hypertension (High Blood Pressure) 01/2022 - 01/2020
4	Hepatocellular Carcinoma (Hepatoma) 05/2019 - 01/2011
3	Demyelinating Diseases (Demyelinating Disease) 11/2013 - 11/2009
3	Alzheimer Disease (Alzheimer's Disease) 04/2007 - 01/2005
2	Inflammation (Inflammations) 02/2021 - 06/2016
2	Dysbiosis 09/2020 - 07/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 05/2019 - 01/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2007 - 01/2005
2	Amyloid Plaque 04/2005 - 01/2005
1	Multiple Sclerosis 01/2022
1	Starvation 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Body Weight (Weight, Body) 02/2021
1	Fibrosis (Cirrhosis) 02/2021
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Cardiomegaly (Heart Hypertrophy) 12/2019
1	Chronic Disease (Chronic Diseases) 12/2019
1	Hypoxia (Hypoxemia) 01/2017
1	Rheumatoid Arthritis 06/2016
1	Synovitis 06/2016
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2013
1	Neuroinflammatory Diseases 11/2013
1	Ischemic Stroke 03/2013
1	Disease Progression 01/2012
1	Hyperinsulinism (Hyperinsulinemia) 06/2009

Drug/Important Bio-Agent (IBA)

6	SaltsIBA 01/2022 - 01/2020
4	Acetates (Acetic Acid Esters)FDA Link 02/2021 - 02/2011
4	Choline (Choline Chloride)IBA 07/2011 - 01/2009
3	FructoseIBA 01/2022 - 07/2020
3	Desoxycorticosterone (Deoxycorticosterone)IBA 02/2021 - 01/2020
3	Amyloid (Amyloid Fibrils)IBA 04/2007 - 01/2005
2	Sodium Chloride FDA LinkGeneric 01/2022 - 07/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
2	N-methyl-4,4'-diaminostilbeneIBA 01/2022 - 11/2013
2	Drinking WaterIBA 01/2022 - 07/2020
2	Desoxycorticosterone Acetate (DOCA)FDA Link 02/2021 - 01/2020
2	Angiotensin IIIBA 02/2021 - 12/2019
2	Butyric Acid (Butanoic Acid)IBA 02/2021 - 12/2019
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2020 - 01/2020
2	InflammasomesIBA 10/2020 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 02/2011 - 06/2009
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2010 - 01/2009
1	OxidesIBA 01/2022
1	NADP (NADPH)IBA 01/2022
1	EnzymesIBA 01/2022
1	Free RadicalsIBA 01/2022
1	MagnesiumIBA 01/2022
1	ivosidenibIBA 01/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	AlbuminsIBA 02/2021
1	Vancomycin FDA LinkGeneric 07/2020
1	NADPH Oxidase 4IBA 01/2020
1	Carbonic Anhydrase IXIBA 01/2020
1	superoxide dismutase 2IBA 01/2020
1	LactonesIBA 01/2020
1	NitrogenIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	4-hydroxy-7-oxo-5-heptenoic acid lactoneIBA 01/2020
1	Dinoprostone (PGE2)FDA Link 12/2019
1	Carboxylic AcidsIBA 05/2019
1	Methionine (L-Methionine)FDA Link 05/2019
1	Proteins (Proteins, Gene)FDA Link 05/2019
1	AcidsIBA 05/2019
1	Amino Acids FDA Link 05/2019
1	Oxygen-17IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Angiogenesis InhibitorsIBA 01/2017
1	PyrrolesIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	fluoromisonidazoleIBA 01/2017
1	Growth InhibitorsIBA 01/2017
1	tofacitinibIBA 06/2016
1	Janus Kinase InhibitorsIBA 06/2016
1	Methotrexate (Mexate)FDA LinkGeneric 06/2016
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 11/2013
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 03/2013
1	Contrast MediaIBA 01/2012
1	CuprizoneIBA 02/2011
1	LipidsIBA 01/2011
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2010
1	Carbon-11IBA 11/2009
1	O-(biotinylcarbazoylmethyl)hydroxylamineIBA 11/2009
1	Temozolomide (Temodar)FDA LinkGeneric 11/2009
1	Photosensitizing Agents (Photosensitizers)IBA 01/2009
1	Coloring Agents (Dyes)IBA 04/2005

Therapy/Procedure

6	Therapeutics 07/2020 - 01/2005
2	Photochemotherapy (Photodynamic Therapy) 01/2010 - 01/2009
1	Oral Administration 02/2021
1	Radiotherapy 01/2020